Birth control pills and nonprofessional voice: Acoustic analyses

Journal of Speech, Language, and Hearing Research

Volumn 49, Issue 5, 2006, Pages 1114-1121

  Amir, Ofer ^a   Biron Shental, Tal ^b   Shabtai, Esther ^c  

^a SHEBA MEDICAL CENTER   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acoustic measurements; Birth control pills; Hormones; Voice assessment; Women

Indexed keywords

ALDOSTERONE ANTAGONIST; ANDROSTANE DERIVATIVE; DESOGESTREL; DROSPIRENONE; GESTODENE; LYNESTRENOL; ORAL CONTRACEPTIVE AGENT; PREGNANE DERIVATIVE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; META ANALYSIS; RECORDING; REGRESSION ANALYSIS; SPEECH; SPEECH ANALYSIS; VOICE;

ADULT; ALDOSTERONE ANTAGONISTS; ANDROSTENES; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, SYNTHETIC; DESOGESTREL; FEMALE; HUMANS; LYNESTRENOL; NORPREGNENES; REGRESSION ANALYSIS; SPEECH ACOUSTICS; SPEECH PRODUCTION MEASUREMENT; TAPE RECORDING; VOICE QUALITY;

EID: 39049182463     PISSN: 10924388     EISSN: None     Source Type: Journal    
DOI: 10.1044/1092-4388(2006/080)     Document Type: Article

References (50)

1. Abitbol, J., & Abitbol, B. (1998). The voice and menopause: The twilight of the divas. Contraception, Fertilite, Sexualite, 26, 649-655.
2. Abitbol, J., Abitbol, P., & Abitbol, B. (1999). Sex hormones and the female voice. Journal of Voice, 13, 424-446.
3. Abitbol, J., de Brux, J., Millot, G., Masson, M. F., Momoun, O. L., Pau, H., & Abitbol, B. (1989). Does a hormonal vocal cord cycle exist in women? Study of vocal premenstrual syndrome in voice performers by videostroboscopy-glotography and cytology on 38 women. Journal of Voice, 2, 157-162.
4. Amir, O., & Biron-Shental, T. (2003). Do oral contraceptives really have an adverse effect on voice quality? In Models and Analysis of Vocal Emissions for Biomedical Applications (MAVEBA): Proceedings of the Third International Workshop, 161-164.
5. Amir, O., & Biron-Shental, T. (2004). The impact of hormonal fluctuations on female vocal folds. Current Opinion in Otolaryngology & Head and Neck Surgery, 12, 180-184.
6. Amir, O., Biron-Shental, T., Muchnik, C., & Kishon-Rabin, L. (2003). Do oral contraceptives improve vocal quality? Limited trial on low-dose formulations. Obstetrics & Gynecology, 101, 773-777.
7. Amir, O., Biron-Shental, T., Tzenker, O., & Barer, T. (2005). Different oral contraceptives and voice quality-An observational study. Contraception, 71, 348-352.
8. Amir, O., & Kishon-Rabin, L. (2004). Association between birth control pills and voice quality. Laryngoscope, 114, 1021-1026.
9. Amir, O., Kishon-Rabin, L., & Muchnik, C. (2002). The effect of oral-contraceptives on voice: Preliminary observations. Journal of Voice, 16, 267-273.
10. Baken, R. J. (1997). Clinical measurement of speech and voice (2nd ed., pp. 95-197). London: Singular.
11. Boulet, M. J., & Oddens, B. J. (1996). Female voice changes around and after the menopause: An initial investigation. Maturitas, 23, 15-21.
12. Chae, S. W., Choi, G., Kang, H. J., Choi, J. O., & Jin, S. M. (2001). Clinical analysis of voice change as a parameter of premenstrual syndrome. Journal of Voice, 15, 278-283.
13. Colton, R. H., & Casper, J. K. (1996). Understanding voice problems: A physiological perspective for diagnosis and treatment (2nd ed., pp. 186-240). Baltimore: Williams & Wilkins.
14. Czaonkowska, A., Ciesielska, A., & Joniec, I. (2003). Influence of estrogens on neurodegenerative processes. Medical Science Monitor, 9, RA247-256.
15. Davis, C. B., & Davis, M. L. (1993). The effect of premenstrual syndrome (PMS) on the female singer. Journal of Voice, 7, 337-353.
16. Glass, G. V. (1976). Primary, secondary and meta-analysis of research. Educational Researcher, 10, 3-8.
17. Gorham-Rowan, M. M. (2004). Acoustic measures of vocal stability during different speech tasks in young women using oral contraceptives: A retrospective study. The European Journal of Contraception and Reproductive Health Care, 9, 166-172.
18. Gorham-Rowan, M., Langford, A., Corrigan, K., & Snyder, B. (2004). Vocal pitch levels during connected speech associated with oral contraception use. Journal of Obstetrics and Gynaecology, 24, 284-286.
19. Hampson, E., & Kimura, D. (1988). Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behavioral Neuroscience, 102, 456-459.
20. Hedges, L. V., & Olkin, I. (1985). Statistical methods for meta-analysis. New York: Academic Press.
21. Higgins, M. B., & Saxman, J. H. (1989). Variations in vocal frequency perturbation across the menstrual cycle. Journal of Voice, 3, 233-243.
22. Horii, Y. (1980). Vocal shimmer in sustained phonation. Journal of Speech and Hearing Research, 23, 202-209.
23. Kaplan, B. (1995). Desogestrel, norgestimate, and gestodene: The newer progestins. Annals of Pharmacotherapy, 29, 736-742.
24. Kay Elemetrics Corp. (1999). Multi-Dimensional Voice Program-MDVP model 5105, ver. 2: Software instruction manual. Lincoln Park, NJ: Author.
25. Kuhl, H. (1997). Pharmacokinetics of the newer progestogens and the controversy about gestodene. Contraception, 56, 401-403.
26. Lã, F., Davidson, J., Ledger, W., & Howard, D. (2004, October). The influence of the menstrual cycle and the oral contraceptive pill on the female operatic singing voice. Paper presented at the Second International Physiology and Acoustics of Singing Conference, Denver, CO.
27. Lã, F., Davidson, J., Ledger, W., Howard, D. M., & Jones, G. (2005, September). The effect of third generation contraceptive pill on the classical trained voice. Paper presented at The Sixth Pan European Voice Conference (PEVOC6), London, England.
28. Ladefoged, P. (1982). A course in phonetics (2nd ed., pp. 165-196). San Diego, CA: Harcourt Brace Jovanovich.
29. Ludicke, F., Gaspard, U. J., Demeyer, F., Scheen, A., & Lefebvre, P. (2002). Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism. Contraception, 66, 411-415.
30. Maitra, N., Kulier, R., Blomenkamp, K. W., Helmerhorst, F. M., & Gulmezoglu, A. M. (2004). Progestogens in combined oral contraceptives for contraception. Cochrane Database Systematic Review, 3, CD004861.
31. Most, T., Amir, O., & Tobin, Y. (2000). The Hebrew vowel system: Raw and normalized data. Language & Speech, 43, 295-308.
32. Newman, S. R., Butler, J., Hammond, E. H., & Gray, S. D. (2000). Preliminary report on hormone receptors in the human vocal fold. Journal of Voice, 14, 72-81.
33. Newton, J. R. (1995). Classification and comparison of oral contraceptives containing new generation progestogens. Human Reproduction Update, 1, 231-263.
34. Oelkers, W. (2004). Drospirenone, a progestogen with antimineralocorticoid properties: A short review. Molecular and Cellular Endocrinology, 217, 255-261.
35. Orlikoff, R. F., & Baken, R. J. (1989). The effect of the heartbeat on vocal fundamental frequency perturbation. Journal of Speech and Hearing Research, 32, 576-582.
36. Sanders, G., & Wenmoth, D. (1998). Verbal and music dichotic listening tasks reveal variations in function cerebral asymmetry across the menstrual cycle that are phase and task dependent. Neuropsychologia, 36, 869-874.
37. Sataloff, R. T., Hawkshaw, M., & Rosen, D. C. (1997). Medications: Effect and side effects on professional voice users. In R. T. Sataloff (Ed.), Professional voice (pp. 457-469). San Diego, CA: Singular.
38. Saucier, D. M., & Kimura, D. (1998). Interpersonal motor but not extrapersonal targeting skill is enhanced during the midluteal phase of the menstrual cycle. Developmental Neuropsychology, 14, 385-398.
39. Schwarzer, R. (1989). Meta: Meta-analysis Programs, Version. 5.3 [Computer software]. Raleigh, NC: National Collegiate Software Clearinghouse. Available at http://www.RalfSchwarzer.de
40. Silverman, E. M., & Zimmer, C. H. (1978). Effect of the menstrual cycle on voice quality. Archives of Otolaryngology, 104, 7-10.
41. Sitruk-Ware, R. (2002). New progestogens: A review of their effects in premenopausal and postmenopausal women. European Journal of Contraception & Reproductive Health Care, 3, 19-26.
42. Sorensen, D., & Horii, Y. (1983). Frequency and amplitude perturbation in the voices of female speakers. Journal of Communication Disorders, 16, 57-61.
43. Speroff, L., Glass, R. H., & Kase, N. G. (1999). Clinical gynecologic endocrinology and infertility (6th ed.). Baltimore: Lippincott Williams & Wilkins.
44. Spinelli, A., Talamanca, I. F., & Lauria, L. (2000). Patterns of contraceptive use in 5 European countries. American Journal of Public Health, 90, 1403-1408.
45. Titze, I. R. (1995). Workshop on acoustic voice analysis: Summary statement. Iowa City, IA: National Center for Voice and Speech, University of Iowa.
46. Titze, I. R. (2000). Principles of voice production. Iowa City, IA: National Center for Voice and Speech, University of Iowa.
47. Thorneycroft, I. H. (2002). Yasmin: The reason why. European Journal of Contraception & Reproductive Health Care, 3, 13-18.
48. Wendler, J., Siegert, C., Schelhorn, P., Klinger, G., Gurr, S., Kaufmann, J., Aydinlik, S., & Braunschweig, T. (1995). The influence of Microgynon and Diane-35, two subfifty ovulation inhibitors, on voice function in women. Contraception, 52, 343-348.
49. Whiteside, S. P., Hanson, A., & Cowell, P. E. (2004). Hormones and temporal components of speech: Sex differences and effects of menstrual cyclicity on speech. Neuroscience Letters, 367, 44-47.
50. Wilde, M. I., & Balfour, J. A. (1995). Gestodene: A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations. Drugs, 50, 364-395.